| Value | ₹35.00 Cr |
|---|
BSE filing, NSE: BACPHAR. Summary written from the filing by ALFA Finder's alert engine.
Bacil Pharma Ltd: key numbers
- Share price
- ₹17.45
- Market cap
- ₹25.05 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 39.6×Sector 37.9×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bacil Pharma Ltd
All →Bacil Pharma Other Announcement
Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr
Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Bacil Pharma Management Change
Mr. Dikshant Singh Panwar has resigned as Whole-Time Company Secretary and Compliance Officer of Bacil Pharma Limited, effective October 8, 2026.
Bacil Pharma Board Meeting Date
Bacil Pharma will hold a board meeting on October 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Bacil Pharma Annual Report
Bacil Pharma Limited submitted its 39th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 23, 2026, via video conferencing.
Bacil Pharma Annual General Meeting
Bacil Pharma Limited has announced book closure dates from September 17 to September 23, 2026, for its 39th Annual General Meeting.
Other partnership announcements
All →V2 Retail Partnership
V2 Retail signed a long-term exclusive partnership giving Cupid 400 sq ft across 425+ stores and future stores. Products are targeted network-wide by mid-December 2026.
- Execution
- Long-term, with supply targeted across the network by mid-December 2026
Ravindra Energy Partnership
Ravindra Energy's jointly controlled company EIM signed a strategic MoU with Sorigin Green Mobility. The MoU targets 500 electric heavy commercial vehicles over two years.
- Execution
- 2 years
- electric heavy commercial vehicles deployment
- 500.0 vehicles
Alembic Pharmaceuticals Partnership
Alembic Pharmaceuticals expanded its strategic collaboration with DifGen Pharmaceuticals to commercialize over 20 complex generic products in the US. The portfolio targets a US$5 billion market.
- From
- DifGen Pharmaceuticals
- Execution
- Initial launches from FY28
Grasim Industries Partnership
Grasim Industries, Aditya Birla Renewables, and Suzlon Energy signed a Memorandum of Understanding to develop India's first recyclable wind turbine blades. The partnership utilizes Grasim's Recyclamine technology.
Kothari Industrial Corporation Partnership
Kothari Industrial Corporation signed a five-year MoU with The University of Western Australia. The collaboration spans education, research, mentorships and internships via the UWA Global Engagement Alliance.
- From
- The University of Western Australia (UWA), Australia
- Execution
- five years from the date of the last signature
Rose Merc Partnership
Rose Merc Ltd signed a Lead Marketing, Sales and Project Collaboration Agreement with CATS Eco Systems. No fixed contract value is specified, and no shares are issued.
- Execution
- Five years from November 3, 2026, subject to renewal or earlier termination